Zenlabs Ethica (BOM:530697) Total Liabilities: ₹286.9 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530697 Zenlabs Ethica Ltd BOM:530697
55 GF Score
Price ₹28.00
GF Value ₹29.14
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Zenlabs Ethica Total Liabilities?

Zenlabs Ethica BOM:530697 -3.61% 55 Total Liabilities is ₹286.9 Mil as of Mar. 2026. GuruFocus rates BOM:530697 with a GF Score™ of 55/100 and a GF Value™ of ₹29.14 (Fairly Valued). The stock has 3 warning signs investors should review.

Zenlabs Ethica's Total Liabilities for the quarter that ended in Mar. 2026 was ₹286.9 Mil.

Zenlabs Ethica's quarterly Total Liabilities declined from Sep. 2025 (₹292.81 Mil) to Dec. 2025 (₹0.00 Mil) but then increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹286.92 Mil).

Zenlabs Ethica's annual Total Liabilities increased from Mar. 2024 (₹301.35 Mil) to Mar. 2025 (₹301.97 Mil) but then declined from Mar. 2025 (₹301.97 Mil) to Mar. 2026 (₹286.92 Mil).

Zenlabs Ethica Total Liabilities Historical Data

* Premium members only.

The historical data trend for Zenlabs Ethica's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenlabs Ethica Total Liabilities Chart

Zenlabs Ethica Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 285.65 337.90 301.35 301.97 286.92

Zenlabs Ethica Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 301.97 0.00 292.81 0.00 286.92
BOM:530697
55GF Score
Zenlabs Ethica Ltd BOM:530697
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenlabs Ethica Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Zenlabs Ethica's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=271.168+(4.821+6.727
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+4.205+0)
=286.9

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=372.064-85.143
=286.9

Zenlabs Ethica's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=271.168+(4.821+6.727
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+4.205+0)
=286.9

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=372.064-85.143
=286.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹286.9 Mil mean?
Zenlabs Ethica (BOM:530697) has a Total Liabilities of ₹286.9 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Zenlabs Ethica and its competitors.
Is Zenlabs Ethica's Total Liabilities too high?
Zenlabs Ethica's current Total Liabilities is ₹286.9 Mil. Overall, Zenlabs Ethica has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zenlabs Ethica's Total Liabilities compare to MCK and CAH?
Zenlabs Ethica's Total Liabilities of ₹286.9 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Distribution company?
A good Total Liabilities depends on the Medical Distribution industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Zenlabs Ethica and its competitors. Zenlabs Ethica's current Total Liabilities is ₹286.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenlabs Ethica stock overvalued right now?
Based on GuruFocus' analysis, Zenlabs Ethica (BOM:530697) is currently considered Fairly Valued. The stock's GF Value™ is ₹29.14, compared to a current price of ₹28.00 — trading 3.9% below its estimated fair value. The current Total Liabilities is ₹286.9 Mil. Zenlabs Ethica's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Zenlabs Ethica (BOM:530697), the current Total Liabilities is ₹286.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zenlabs Ethica (BOM:530697) Overvalued in 2026?

Based on GuruFocus' analysis, Zenlabs Ethica stock appears to be undervalued. The current stock price of ₹28.00 is trading 3.9% below its estimated GF Value™ of ₹29.14. GuruFocus considers Zenlabs Ethica to be Fairly Valued.

Key valuation signals for BOM:530697:

  • Total Liabilities: ₹286.9 Mil
  • GF Value™: ₹29.14 vs. price of ₹28.00 (3.9% below fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the BOM:530697 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zenlabs Ethica Business Description

Address Plot No.194-195, 3rd Floor, Industrial Area, Phase-II, Ram Darbar, Chandigarh, IND, 160002
Zenlabs Ethica Ltd is a pharmaceutical company engaged in the trading of pharmaceutical formulations. It manufactures and markets drugs which include Gastrointestinal disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps, and anti-Bacterial drugs, nutraceuticals, and others. In addition, The company offers more than 600 products across therapeutic segments.
55GF Score

Get the complete analysis for BOM:530697

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹28.00
Price
₹29.14
GF Value